KHALIULLIN, F.A.,
KLEN, E.E.,
PAVLOV, V.N.,
SAMORODOV, A.V.,
SHEPILOVA, S.O.,
MAKAROVA, N.N.,
NURLANOVA, S.N.,
ABZALILOV, T.N. (2022)
studies of the antiplatelet, anticoagulant, and
antioxidant activity revealed promising compounds
-crown-6 ether in toluene. In vitro anticoagulant and antiplatelet
activity of the adduct was studied
Khaliullin, F.A.,
Klen, E.E.,
Nikitina, I.L.,
Pavlov, V.N.,
Rozit, G.A.,
Gaisina, G.G.,
Samorodov, A.V. (2023) . An in vivo study of the antidepressant
activity revealed the promising compound 1-(1,1-dioxidothietan-3-yl)-4
Klen, E.E.,
Nikitina, I.L.,
Khaliullin, F.A.,
Shepilova, S.O.,
Nikitina, E.A.,
Gaisina, G.G.,
Samorodov, A.V.,
Pavlov, V.N. (2024) bioavailability. The compounds exhibited varying degrees of antidepressant
activity after a single intraperitoneal
Khaliullin, F. A.,
Klen, E. E.,
Nikitina, I. L.,
Pavlov, V. N.,
Rozit, G. A.,
Gaisina, G. G.,
Samorodov, A. V. (2023) . An in vivo
study of the antidepressant
activity revealed the promising compound 1-(1,1-dioxidothietan-3-yl)-4
Qian, J.,
Zhuang, F.,
Chen, Y.,
Fan, X.,
Wang, J.,
Wang, Z.,
Wang, Y.,
Xu, M.,
Samorodov, A.V.,
Pavlov, V.N.,
Liang, G. (2022) under high glucose condition, which was mediated by p38MAPK
activation. MD2 knockout or pharmacological
Yang, L.,
Luo, W.,
Zhang, Q,
Hong, S.,
Wang, Y.,
Samorodov, A.V.,
Chattipakorn, N.,
Pavlov, V.N.,
Liang, G. (2021) compounds were screened for their anti-inflammatory
activity in LPS-stimulated macrophages. PCR array, SPR